Related Experiment Video
Updated: May 22, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at
Jeffrey J Wallin1, Jane Guan, Kyle A Edgar
1Department of Cancer Signaling and Translational Oncology, Genentech, Inc., South San Francisco, California, USA. jwallin@gene.com
Abstract:
The PTEN/PI3K pathway is commonly mutated in cancer and therefore represents an attractive target for therapeutic intervention. To investigate the primary phenotypes mediated by increased pathway signaling in a clean, patient-relevant context, an activating PIK3CA mutation (H1047R) was knocked-in to an endogenous allele of the MCF10A non-tumorigenic human breast epithelial cell line. Introduction of an endogenously mutated PIK3CA allele resulted in a marked epithelial-mesenchymal transition (EMT) and invasive phenotype, compared to isogenic wild-type cells. The invasive phenotype was linked to enhanced PIP(3) production via a S6K-IRS positive feedback mechanism. Moreover, potent and selective inhibitors of PI3K were highly effective in reversing this phenotype, which is optimally revealed in 3-dimensional cell culture. In contrast, inhibition of Akt or mTOR exacerbated the invasive phenotype. Our results suggest that invasion is a core phenotype mediated by increased PTEN/PI3K pathway activity and that therapeutic agents targeting different nodes of the PI3K pathway may have dramatic differences in their ability to reverse or promote cancer metastasis.
Insights
Activating mutations in the PTEN/PI3K pathway drive cancer invasion. PI3K inhibitors reversed this effect, but Akt or mTOR inhibition worsened it, highlighting targeted therapy differences.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The Phosphatase and Tensin homolog (PTEN)/Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) pathway is frequently altered in various cancers.
- Dysregulation of this pathway promotes tumorigenesis and metastasis, making it a key therapeutic target.
Purpose of the Study:
- To investigate the direct cellular consequences of increased PTEN/PI3K pathway signaling.
- To evaluate the efficacy of targeting different nodes within the PI3K pathway in a relevant cellular model.
Main Methods:
- An activating mutation (H1047R) in PIK3CA was introduced into MCF10A human breast epithelial cells.
- Cells were cultured in 3D to assess epithelial-mesenchymal transition (EMT) and invasion.
- The effects of PI3K, Akt, and mTOR inhibitors were evaluated.
Main Results:
- Endogenous PIK3CA mutation induced a significant epithelial-mesenchymal transition (EMT) and invasive phenotype.
- Enhanced invasion was associated with increased PIP(3) production mediated by a S6K-IRS feedback loop.
- Selective PI3K inhibitors effectively reversed the invasive phenotype.
- Inhibition of Akt or mTOR paradoxically exacerbated invasion.
Conclusions:
- Increased PTEN/PI3K pathway activity is a core driver of cancer cell invasion.
- Targeting PI3K directly is effective in reversing invasion, while targeting downstream effectors like Akt or mTOR may have adverse outcomes.
- Therapeutic strategies targeting the PI3K pathway require careful consideration of the specific node being inhibited to avoid promoting metastasis.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
piRNA - Piwi-interacting RNAs
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Hedgehog Signaling Pathway

